Dachaigh › Hemophilia B
Sgrùdaidhean clionaigeach Hemophilia B a’ fastadh anns na SA
Tha 12 sgrùdaidhean airson Hemophilia B a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Philadelphia, PA5 sgrùdaidhean
- Sacramento, CA4 sgrùdaidhean
- Atlanta, GA4 sgrùdaidhean
- Houston, TX4 sgrùdaidhean
- Los Angeles, CA4 sgrùdaidhean
- Ann Arbor, MI4 sgrùdaidhean
- Indianapolis, IN3 sgrùdaidhean
- Seattle, WA3 sgrùdaidhean
- San Francisco, CA3 sgrùdaidhean
- Nashville, TN3 sgrùdaidhean
- Greenville, NC3 sgrùdaidhean
- Gainesville, FL3 sgrùdaidhean
Le stàit
- California7 sgrùdaidhean
- Florida4 sgrùdaidhean
- Georgia4 sgrùdaidhean
- Indiana3 sgrùdaidhean
- Louisiana3 sgrùdaidhean
- Michigan6 sgrùdaidhean
- Missouri3 sgrùdaidhean
- New York5 sgrùdaidhean
- North Carolina4 sgrùdaidhean
- Ohio3 sgrùdaidhean
- Pennsylvania6 sgrùdaidhean
- Tennessee4 sgrùdaidhean
- Texas4 sgrùdaidhean
- Washington3 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 2 Dàmh 2026 · NCT05568719A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
A’ fastadhÌre 3
Aoisean 1 gu 17 · Fir · Air ùrachadh 23 Sult 2026 · NCT05611801Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
A’ fastadhÌre 3
138 Months – 206 Months · Fir · Air ùrachadh 16 Sult 2026 · NCT07080905A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
A’ fastadhÌre 1/2
Aoisean 2 agus nas sine · Fir · Air ùrachadh 11 Sult 2026 · NCT06379789Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Lùna 2026 · NCT06003387SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
A’ fastadhÌre 3
Aoisean 6 agus nas sine · Gach gnè · Air ùrachadh 21 Lùna 2026 · NCT04563520ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT04398628A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 60 · Gach gnè · Air ùrachadh 2 Iuch 2026 · NCT06349473Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
A’ fastadhÌre 3
Aoisean 1 gu 74 · Fir · Air ùrachadh 1 Iuch 2026 · NCT05145127ATHNdataset Registry
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 21 Gibl 2026 · NCT06820515An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Gearr 2026 · NCT06008938SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
A’ fastadhÌre 4
Aoisean 12 gu 100 · Gach gnè · Air ùrachadh 12 Faoi 2026 · NCT04647227Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.